0

NCX-4016 NicOx

Mario Di Napoli, Francesca Papa

Curr Opin Investig Drugs. 2003 Sep;4(9):1126-39.

PMID: 14582459

Abstract:

NCX-4016 is a nitric oxide-aspirin conjugate non-steroidal anti-inflammatory drug that is under investigation by NicOx for the potential treatment of cardiovascular disorders and colon cancer. In April 2002, a phase II clinical trial was initiated in symptomatic peripheral arterial disease, and in March 2003, the University of Michigan was awarded a grant by the NIH to conduct a phase II trial in individuals at risk of colon cancer.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP175033360 NCX 4016 NCX 4016 175033-36-0 Price
qrcode